CYTKCytokinetics Inc
CYTK
Cytokinetics Inc4,462
Mkt Cap
$7.2BVolume
1.88M52W High
$64.1352W Low
$29.31PE Ratio
-9.54CYTK Fundamentals
Price
$60.16Prev Close
$60.30Open
$60.2050D MA
$55.26Beta
0.92Avg. Volume
1.82MEPS (Annual)
-$5.26P/B
-14.10Rev/Employee
$37,096.39DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics PR...
PR Newswire·17h ago
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit...
PR Newswire·20h ago
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK)
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK) Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action...
PR Newswire·1d ago
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS...
PR Newswire·2d ago
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities...
PR Newswire·2d ago
Cytokinetics (NASDAQ:CYTK) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Cytokinetics (NASDAQ:CYTK - Get Free Report) announced its earnings results on Wednesday. The biopharmaceutical company reported ($1.54) EPS for the quarter, beating analysts' consensus estimates of...
MarketBeat·2d ago
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Cytokinetics
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated (Cytokinetics or the Company) (NASDAQ: CYTK). Faruqi & Faruqi is a...
Business Wire·2d ago
The Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
The Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK The Gross Law Firm Reminds Cytokinetics Investors of...
PR Newswire·2d ago
Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) delivered earnings and revenue surprises of +3.14% and -65.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK Cytokinetics, Incorporated Sued for Securities Law...
PR Newswire·4d ago